Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The mRNA for the Duffy blood group antigen, the erythrocyte receptor for the Plasmodium vivax malaria parasite, has recently been cloned and shown to encode a widely expressed chemokine receptor. Here, we show that the Duffy antigen/chemokine receptor gene (DARC) is composed of a single exon and that most Duffy-negative blacks carry a silent FY*B allele with a single T to C substitution at nucleotide -46. This mutation impairs the promoter activity in erythroid cells by disrupting a binding site for the GATA1 erythroid transcription factor. With the recent characterization of the FY*A and FY*B alleles, these findings provide the molecular basis of the Duffy blood group system and an explanation for the erythroid-specific repression of the DARC gene in Duffy-negative individuals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DARC is an atypical chemokine receptor and the antigen of the Duffy (Fy) blood group system (Tournamille et al., 1995; Tournamille et al., 1998; Wasniowska and Hadley, 1994).”
From Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes (2015) · cites this paper as Tournamille et al., 1995
In the citing paper
“A substantial part of the human population carries a homozygous mutation (FY*AES or FY*BES alleles for erythrocyte silent) in the erythroid-specific promoter of the FY gene, resulting in a lack of expression of the receptor on erythrocytes (Fya−/b− phenotype) but not in non-erythroid tissues (Tournamille et al., 1995; Zimmerman et al., 1999).”
From Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes (2015) · cites this paper as Tournamille et al., 1995
Citations
Cites
Luckow, B., & Schütz, G. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.13.5490 · Cited by 1,701
MODEL SYSTEMS FOR THE STUDY OF SEVEN-TRANSMEMBRANE-SEGMENT RECEPTORS
Dohlman, H. G., Thorner, J., Caron, M. G., & Lefkowitz, R. J. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.003253 · Cited by 1,379
The Resistance Factor to Plasmodium vivax in Blacks: The Duffy-Blood-Group Genotype,FyFy
Miller, L. H., Mason, S. J., Clyde, D. F., & McGinniss, M. H. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608052950602 · Cited by 1,260
Race, R. R., & Sanger, R. A. (1962) · Medical Entomology and Zoology · Cited by 1,162
Compilation of vertebrate-encoded transcription factors
Faisst, S., & Meyer, S. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.1.3 · Cited by 914
GATA-binding transcription factors in hematopoietic cells
Orkin, S. (1992) · Blood · doi:10.1182/blood.v80.3.575.575 · Cited by 884
Erythrocyte Receptors for ( Plasmodium Knowlesi ) Malaria: Duffy Blood Group Determinants
Miller, L. H., Mason, S. J., Dvorak, J. A., McGinniss, M. H., & Rothman, I. K. (1975) · Science · doi:10.1126/science.1145213 · Cited by 610
Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin.
Darbonne, W. C., Rice, G. C., Mohler, M. A., Apple, T., Hébert, C. A., Valente, A. J., & Baker, J. B. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115442 · Cited by 452
Globin gene regulation and switching: Circa 1990
Orkin, S. H. (1990) · Cell · doi:10.1016/0092-8674(90)90133-y · Cited by 442
Chitnis, C. E., & Miller, L. H. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.497 · Cited by 426
Research works printed but not linked: 1
- Toumamilte, C., Le Van Kim, C., Gane, P., Cartron, J.P. & Colin, Y. Molecular basis and PCR-DNA typing of the Pya/Pyb blood group polymorphism. Hum. Genet. 85, 407–410 (1995).
Cited by
Items 201–300 of 742
The Duffy Antigen Receptor for Chemokines DARC/ACKR1
Horuk, R. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00279 · Cited by 61
“A promoter mutation in the GATA box of the Duffy gene prevents its expression on erythrocytes (3) and most West Africans are resistant to P.”
BackgroundMolecular basis of the Duffy blood group system.
Höher, G., Fiegenbaum, M., & Almeida, S. (2018) · Blood transfusion · doi:10.2450/2017.0119-16 · Cited by 72
Regulation of chemotactic networks by ‘atypical’ receptors
Comerford, I., Litchfield, W., Harata‐Lee, Y., Nibbs, R. J. B., & McColl, S. R. (2007) · BioEssays · doi:10.1002/bies.20537 · Cited by 60
“The relative resistance to malarial infection conferred to individuals who lack DARC expression on erythrocytes has selected for humans who do not express DARC in these cells.((53)) These erythrocyte DARC-negative humans display reduced plasma levels of CCL2 compared with DARC-positive individuals((54)) and injected c…”
BackgroundGoheen, M. M., Campino, S. G., & Cerami, C. (2017) · British Journal of Haematology · doi:10.1111/bjh.14886 · Cited by 71
“…termed DARC, FY) gene promoter which affects GATA1 transcription factor binding – specifically, the GATA1 transcription factor for erythroid lineage cells (thus DARC expression elsewhere is unaffected) [(Tournamille et al, 1995) and reviewed in Livingstone (1984); Grimberg et al (2007)].”
BackgroundErythro-megakaryocytic transcription factors associated with hereditary anemia
Crispino, J. D., & Weiss, M. J. (2014) · Blood · doi:10.1182/blood-2014-01-453167 · Cited by 69
“For example, theRBCDuffy antigen null phenotype, a relatively common allele in Africans that confers resistance to Plasmodium vivax malaria, is caused by a mutation that disrupts a GATA1 binding site in theDuffy antigen/chemokine receptor gene (DARC) promoter.(26) X-linked sideroblastic anemia in some patients is asso…”
BackgroundOlson, M. V. (2012) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090711-163825 · Cited by 58
“The most extreme example appears to be a promoter mutation in the DARC gene, which accounts for nearly all occurrences of the Duffy-negative blood type (104, 114).”
BackgroundPavenski, K., Saidenberg, E., Lavoie, M., Tokessy, M., & Branch, D. R. (2011) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2011.07.003 · Cited by 61
“The Fy null phenotype, because of a GATA-1 box polymorphism [44], confers resistance to P vivax malaria and has been linked to reduced neutrophil counts in peoples of African ancestry [45].”
BackgroundMendelian and complex genetics of susceptibility and resistance to parasitic infections
Campino, S. G., Kwiatkowski, D. P., & Dessein, A. J. J. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.07.011 · Cited by 56
Toll-like receptor polymorphisms in malaria-endemic populations
Greene, J. A., Moormann, A. M., VULULE, J. M., Bockarie, M. J., Zimmerman, P. A., & Kazura, J. W. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-50 · Cited by 55
“Homozygosity for this allele has not been observed in African populations (e.g. Khor, et al [6] reported no homozygous individuals among the 4902 West and East Africans genotyped in their study.)”
BackgroundThe Origins of African Plasmodium vivax; Insights from Mitochondrial Genome Sequencing
Culleton, R. L., Coban, C., Zeyrek, F. Y., Cravo, P., Kaneko, A., Randrianarivelojosia, M., Andrianaranjaka, V., Kano, S., Färnert, A., Arez, A. P., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029137 · Cited by 56
“promoter activity by disrupting a binding site for the h-GATA-1 erythroid transcription factor [6].”
BackgroundSmolarek, D., Hattab, C., Hassanzadeh‐Ghassabeh, G., Cochet, S., Gutiérrez, C., de Brevern, A. G., Udomsangpetch, R., Picot, J., Grodecka, M., Waśniowska, K., et al. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0387-6 · Cited by 54
“This selective extinction is due to a mutation in a GATA box of the DARC promoter region [ 8 ]: the GATA transcription factor is driving DARC expression in cells from the erythrocytic lineage while other factors are operating in tissues where DARC is expressed like endothelial cells from the postcapillary venules, Pur…”
BackgroundSelf-citationNovel 3′Rhesus boxsequences confoundRHDzygosity assignment
Matheson, K. A., & Denomme, G. A. (2002) · Transfusion · doi:10.1046/j.1537-2995.2002.00078.x · Cited by 56
Patterns of ethnic diversity among the genes that influence AIDS
Winkler, C. A., An, P., & O'Brien, S. J. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh075 · Cited by 62
“Similarly, the Fy null mutation in the DARC promoter region eliminates the DNA-binding site for the erythroid transcriptional factor GATA 1, leading to altered expression in erythrocytes (but not in other cell types), effectively preventing infection by Plasmodium vivax (67).”
BackgroundWoolley, I. J., Hotmire, K., Sramkoski, R. M., Zimmerman, P. A., & Kazura, J. W. (2000) · Transfusion · doi:10.1046/j.1537-2995.2000.40080949.x · Cited by 56
Lelliott, P. M., McMorran, B. J., Foote, S. J., & Burgio, G. (2015) · Malaria Journal · doi:10.1186/s12936-015-0809-x · Cited by 66
“The SNP prevents erythrocytic expression and results in the Duffy-negative blood phenotype [8].”
BackgroundThe Duffy antigen receptor for chemokines, ACKR 1,– ‘Jeanne DARC ’ of benign neutropenia
Rappoport, N., Simon, A. J., Amariglio, N., & Rechavi, G. (2018) · British Journal of Haematology · doi:10.1111/bjh.15730 · Cited by 57
A Review of Molecular Contrasts Between Arresting and Viable Porcine Attachment Sites
Wessels, J. M., Linton, N. F., Croy, B. A., & Tayade, C. (2007) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2007.00534.x · Cited by 55
Blood group associations with parasites, bacteria, and viruses
Moulds, J. M., & Moulds, J. J. (2000) · Transfusion Medicine Reviews · doi:10.1053/tmrv.2000.16227 · Cited by 57
Detecting natural selection on cis-regulatory DNA
Hahn, M. W. (2006) · Genetica · doi:10.1007/s10709-006-0029-y · Cited by 60
“A single cis -regulatory nucleotide mutation eliminates expression of FY and confers resistance to malaria (Tournamille et al. 1995).”
BackgroundSingle PCR Multiplex SNaPshot Reaction for Detection of Eleven Blood Group Nucleotide Polymorphisms
Cristofaro, J. D., Silvy, M., Chiaroni, J., & Bailly, P. (2010) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2010.090222 · Cited by 54
“For this reason the multiplex assay included probe primes against nucleotide changes known to impair the GYPB and DARC genes reported in individuals of African descent.(31,32) Detection of SNPs defining the alleles of the DO, YT, and CO systems was also included because there are hemolytic transfusion reactions caused…”
MethodVergara, C., Tsai, Y. J., Grant, A. V., Rafaels, N. M., Gao, L., Hand, T. A., Stockton, M. L., Campbell, M., Mercado, D., Faruque, M. U., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-182oc · Cited by 59
“This underlies the molecularbasisfortheDARC-negativephenotype(13)observed inmostsub-SaharanandWestAfricanpopulations(14).”
Molecular genetic blood group typing by the use of PCR‐SSP technique
Prager, M. (2007) · Transfusion · doi:10.1111/j.1537-2995.2007.01311.x · Cited by 54
Hosseini‐Maaf, B., Hellberg, Å., Rodrigues, M. J. A., Chester, M., & Olsson, M. L. (2003) · BMC Genetics · doi:10.1186/1471-2156-4-17 · Cited by 61
“The silent Fy allele (based on the Fyb sequence with a disrupted GATA-1-binding motif in the promoter region [24]) commonly found in individuals of Black ethnic origin but not in Caucasians was detected in the homozygous or heterozygous state in all five cases whilst the RHD pseudogene [23] exclusively found in some B…”
BackgroundThe Immunogenetics of Resistance to Malaria
Hill, A. V. S. (1999) · Proceedings of the Association of American Physicians · doi:10.1046/j.1525-1381.1999.99234.x · Cited by 53
Gene Organization and Promoter Function for CC Chemokine Receptor 5 (CCR5)
Guignard, F., Combadière, C., Tiffany, H. L., & Murphy, P. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.985 · Cited by 56
“An inactivating mutation in a GATA-1 site is present in the Duffy promoter of most Africans and is responsible for natural resistance to vivax malaria (46).”
BackgroundSequence, evolution and ligand binding properties of mammalian Duffy antigen/receptor for chemokines
Tournamille, C., Blancher, A., Kim, C. L. V., Gane, P., Apoil, P. A., Nakamoto, W., Cartron, J., & Colin, Y. (2004) · Immunogenetics · doi:10.1007/s00251-003-0633-2 · Cited by 52
“These results support the hypothesis that FY*B is the ancestral allele (Chaudhuri et al. 1995; Tournamille et al. 1995b) from which FY*A and FY*O derived about 25,000–28,000 and 22,000–55,000 years ago, respectively (Seixas et al. 2002).”
BackgroundMethodResultInfluentialSelf-citationHost resistance to malaria: using mouse models to explore the host response
Longley, R. J., Smith, C. M., Fortin, A., Berghout, J., McMorran, B. J., Burgio, G., Foote, S. J., & Gros, P. (2010) · Mammalian Genome · doi:10.1007/s00335-010-9302-6 · Cited by 64
“Band 3 ovalocytosis Reduced parasite invasion Jarolim et al. 1991 Duffy negative antigen Disruption of the GATA motif in the Duffy gene, resulting in absence of invasion by P. vivax Tournamille et al. 1995”
BackgroundWhat Is Known about the Immune Response Induced by Plasmodium vivax Malaria Vaccine Candidates?
López, C., Yepes-Pérez, Y., Hincapié-Escobar, N., Díaz-Arévalo, D., & Patarroyo, M. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00126 · Cited by 68
“The absence of DARC expression in RBC is due to a point mutation (T46C) in the GATA box of this gene’s promoter (118, 119).”
BackgroundMalaria was a weak selective force in ancient Europeans
Gelabert, P., Olalde, Í., de-Dios, T., Civit, S., & Lalueza‐Fox, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-01534-5 · Cited by 55
Blood group genotyping in multi-transfused patients
Bakanay, Ş. M., Öztürk, A., İleri, T., İnce, E., Yavasoglu, S., Akar, N., Uysal, Z., & Arslan, Ö. (2013) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2013.01.009 · Cited by 51
DARC and D6: silent partners in chemokine regulation?
Hansell, C. A. H., Hurson, C. E., & Nibbs, R. J. B. (2010) · Immunology and Cell Biology · doi:10.1038/icb.2010.147 · Cited by 54
“6 This is thought to have driven emergence of the Duffy null phenotype prominent in African populations, which is usually caused by a homozygous GATA-1-binding site mutation in the DARC promoter”
BackgroundChemokines, their receptors and human disease: the good, the bad and the itchy
Bryant, V. L., & Slade, C. A. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.23 · Cited by 56
Extended Blood Group Molecular Typing and Next-Generation Sequencing
Liu, Z., Liu, M., Mercado, T., Illoh, O., & Davey, R. (2014) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2014.08.003 · Cited by 50
“For example, a mutation in the promoter region (GATA-1) in the DARC gene related to the Duffy blood group system is responsible for the Duffy-null phenotype [40].”
BackgroundPrenatal Determination of Fetal Blood Group Status
Avent, N. D., Finning, K. M., Martin, P. G., & SOOTHILL, P. W. (2000) · Vox Sanguinis · doi:10.1111/j.1423-0410.2000.tb00055.x · Cited by 50
Prospects for targeting ACKR1 in cancer and other diseases
Crawford, K. S., & Volkman, B. F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1111960 · Cited by 58
African Plasmodium vivax: Distribution and origins
Culleton, R. L., & Carter, R. (2012) · International Journal for Parasitology · doi:10.1016/j.ijpara.2012.08.005 · Cited by 48
“In the homozygous state, the Duffy antigen is not transcribed in erythrocyte precursor cells and is completely absent from the erythrocyte surface (Tournamille et al., 1995).”
BackgroundThe landscape of expression and alternative splicing variation across human traits
García-Pérez, R., Ramírez, J. M., Ripoll-Cladellas, A., Chazarra-Gil, R., Oliveros, W., Soldatkina, O., Bosio, M., Rognon, P. J., Capella-Gutiérrez, S., Calvo, M., et al. (2022) · Cell Genomics · doi:10.1016/j.xgen.2022.100244 · Cited by 61
“Among these, some are known to be implicated in trait-related phenotypes, such as ACKR1, the malaria receptor gene, whose lower expression in individuals of African ancestry is associated with higher resistance to malaria infection.(37) Overall, we observe that the associations of each demographic trait on interindivi…”
BackgroundPlasmodium vivax and the Duffy antigen: A paradigm revisited
Mercereau‐Puijalon, O., & Ménard, D. (2010) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2010.06.005 · Cited by 47
“[9,10].”
A novel FY allele in Brazilians
Castilho, L. M., Rios, M., Pellegrino, J., Saad, S. T. O., Costa, F. F., & Reid, M. E. (2004) · Vox Sanguinis · doi:10.1111/j.1423-0410.2004.00554.x · Cited by 47
Multiple Functional Variants in cis Modulate PDYN Expression
Babbitt, C. C., Silverman, J. S., Haygood, R., Reininga, J. M., Rockman, M. V., & Wray, G. A. (2010) · Molecular Biology and Evolution · doi:10.1093/molbev/msp276 · Cited by 46
“Most genes with clear signatures of balancing selection in humans are associated with immune function or protection (e.g., Takahata et al. 1992; Peiper et al. 1995; Tournamille et al. 1995; Verrelli et al. 2002; Tung et al. 2009).”
BackgroundGenetic Determinants and Ethnic Disparities in Sepsis-associated Acute Lung Injury
Barnes, K. C. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200502-013ac · Cited by 53
Malaria and leishmaniasis: Updates on co-infection
Ornellas-Garcia, U., Cuervo, P., & Ribeiro-Gomes, F. L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1122411 · Cited by 45
A cis-Phase Interaction Study of Genetic Variants Within the MAOA Gene in Major Depressive Disorder
Zhang, J., Chen, Y., Zhang, K., Yang, H., Sun, Y., Fang, Y., Shen, Y., & Xu, Q. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.004 · Cited by 55
Host–pathogen interactions revealed by human genome-wide surveys
Khor, C. C., & Hibberd, M. L. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.02.001 · Cited by 50
Pathogenic mechanisms and clinical implications of congenital neutropenia syndromes
Hauck, F. H., & Klein, C. (2013) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000014 · Cited by 49
“an d B ce lls [6 9 – 7 3 ]”
BackgroundInfluentialWaśniowska, K., Blanchard, D., Janvier, D., Wang, Z., Peiper, S. C., Hadley, T. J., & Lisowska, E. (1996) · Molecular Immunology · doi:10.1016/s0161-5890(96)00056-9 · Cited by 45
Vasseur, E., & Quintana‐Murci, L. (2013) · Evolutionary Applications · doi:10.1111/eva.12045 · Cited by 43
Molecular basis of blood group expression
Denomme, G. A. (2011) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2010.12.010 · Cited by 53
“The most obvious SNP leading to an altered phenotype is the promoter region 67C>T in the GATA-1 motif of the Duffy gene [31].”
BackgroundRed blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia
Yee, M. E. M., Josephson, C. D., Winkler, A. M., Webb, J. L., Luban, N. L. C., Leong, T. L., Stowell, S. R., & Fasano, R. M. (2017) · Transfusion · doi:10.1111/trf.14282 · Cited by 42
“For recipients with the FY gene promoter region mutation that prevents erythroid-specific GATA-1 transcription factor binding and erythroid Fy antigen expression, exposure to Fy1 units was not considered to be a mismatch, since these recipients are not at risk for antiFy alloimmunization.(25) For U– (S–s–) patients, e…”
The Role of Genomics in Studying Genetic Susceptibility to Infectious Disease: Figure 1.Preprint
Weatherall, D. J., Clegg, J. B., & Kwiatkowski, D. P. (1997) · Genome Research · doi:10.1101/gr.7.10.967 · Cited by 43
“vivax malaria, has now been defined as a substitution in the binding site for the GATA 1 erythroid transcription factor at position 146 to the promoter (Tournamille et al. 1995).”
BackgroundLuo, H., Chaudhuri, A., Johnson, K. R., Neote, K., Zbrzezna, V., He, Y., & Pogo, A. O. (1997) · Genome Research · doi:10.1101/gr.7.9.932 · Cited by 42
“In the promoter region of this FY*B allele there is a T → C substitution that disrupts a binding site for GATA I erythroid transcription factor (Tournamille et al. 1995a).”
BackgroundInfluentialRole of chemokines polymorphisms in diseases
Guergnon, J., & Combadière, C. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.04.010 · Cited by 42
Herrera, S., Gómez, A., Vera, O., Vergara, J., Valderrama-Aguirre, A., Maestre, A., Méndez, F., Wang, R.-B., Chitnis, C., Yazdani, S., et al. (2005) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2005.73.44 · Cited by 41
“The DNA was extracted by a salting-out technique, and 1 L was used for a nested PCR as previously described.(15) Antibody response to P.”
MethodGenetic diversity of KELnull and KELel: a nationwide Austrian survey
Körmöczi, G. F., Wagner, T., Jungbauer, C., Vadon, M., Ahrens, N., Moll, W., Mühlbacher, A., Özgül‐Gülce, S., Kleinrath, T., Kilga‐Nogler, S., et al. (2007) · Transfusion · doi:10.1111/j.1537-2995.2007.01174.x · Cited by 42
“Obviously, further sites of phenotypealtering mutations in the promoter or intron regions of the KEL gene may be involved, in analogy to other blood group genes, such as known from the gene-silencing promoter mutation in the FY gene, or as yet unidentified genesilencing mutations in certain RHD alleles.(19,20) The maj…”
BackgroundLaso‐Jadart, R., Harmant, C., Quach, H., Zidane, N., Tyler‐Smith, C., Mehdi, Q., Ayub, Q., Quintana‐Murci, L., & Patin, É. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.09.025 · Cited by 42
The epidemiology of Plasmodium vivax among adults in the Democratic Republic of the Congo
Brazeau, N. F., Mitchell, C. L., Morgan, A. P., Deutsch-Feldman, M., Watson, O. J., Thwai, K. L., Gelabert, P., van Dorp, L., Keeler, C., Waltmann, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24216-3 · Cited by 43
Jindal, G. A., Bantle, A., Solvason, J. J., Grudzien, J. L., D’Antonio‐Chronowska, A., Lim, F., Le, S. H., Song, B. P., Ragsac, M. F., Klie, A., et al. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.09.005 · Cited by 50
Jülg, B. D., Reddy, S., van der Stok, M., Kulkarni, S., Qi, Y., Bass, S. E., Gold, B., Nalls, M. A., Nelson, G. W., Walker, B. D., et al. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.04.009 · Cited by 41
“The -46C/C genotype is nearly fixed in those sub-Saharan African populations where Plasmodium vivax is endemic, apparently because it confers resistance against P. vivax malaria, but -46C is virtually absent in individuals of European descent (Tournamille et al., 1995; Hamblin and Di Rienzo, 2000).”
BackgroundHuman knockout research: new horizons and opportunities
Alkuraya, F. S. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.11.003 · Cited by 44
The genomic signatures of natural selection in admixed human populations
Cuadros-Espinoza, S., Laval, G., Quintana‐Murci, L., & Patin, É. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.02.011 · Cited by 43
Prospects for the provision of genotyped blood for transfusion
Denomme, G. A. (2013) · British Journal of Haematology · doi:10.1111/bjh.12476 · Cited by 40
“The GATA1 promoter of the Duffy blood group gene (DARC, previously known as FY) is the best example of a single nucleotide polymorphism (SNP) that must be considered when predicting Fy(a/b) expression (Tournamille et al, 1995).”
BackgroundThe Legacy of Past Pandemics: Common Human Mutations That Protect against Infectious Disease
Pittman, K. J., Glover, L. C., Wang, L., & Ko, D. C. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005680 · Cited by 40
“The absence of Duffy antigen on the surface of erythrocytes in Duffy blood group-negative individuals is due to a mutation in the gene promoter that only alters function in erythrocytes [18].”
BackgroundNébor, D., Durpès, M.-C., Mougenel, D., Mukisi-Mukaza, M., Élion, J., Hardy‐Dessources, M., & Romana, M. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.02.023 · Cited by 42
Antenatal Genotyping of the Blood Groups of the Fetus
Avent, N. D. (1998) · Vox Sanguinis · doi:10.1111/j.1423-0410.1998.tb05444.x · Cited by 42
Winkler, C. A., An, P., Johnson, R. C., Nelson, G. W., & Kirk, G. D. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.04.010 · Cited by 40
“DARC expression on RBC is abolished by the 46T/C transition in the DARC promoter region that disrupts the erythrocytespecific transcription binding site (Tournamille et al., 1995).”
BackgroundCan gene-inactivating mutations lead to evolutionary novelty?
Murray, A. W. (2020) · Current Biology · doi:10.1016/j.cub.2020.03.072 · Cited by 47
Möller, M., Lee, Y. Q., Vidovic, K., Kjellström, S., Björkman, L., Storry, J. R., & Olsson, M. L. (2018) · Blood · doi:10.1182/blood-2018-03-842542 · Cited by 39
Lo, E. Y. Y., Russo, G., Pestana, K., Kepple, D., Abagero, B. R., Dongho, G. B. D., Gunalan, K., Miller, L. H., Hamid, M. M. A., Yewhalaw, D., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.05.009 · Cited by 39
Driest, S. L. V., Abul‐Husn, N. S., Glessner, J., Bastarache, L. A., Nirenberg, S., Schildcrout, J. S., Eswarappa, M. S., Belbin, G. M., Shaffer, C. M., Mentch, F. D., et al. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.3108 · Cited by 40
DARCalleles and Duffy phenotypes in African Americans
Schmid, P., Ravenell, K. R., Sheldon, S. L., & Flegel, W. A. (2011) · Transfusion · doi:10.1111/j.1537-2995.2011.03431.x · Cited by 42
“knowlesi.(2,3,9,10) These FY*B-67C alleles have become the most prevalent DARC alleles in populations living in regions with endemic malaria.”
BackgroundThe evolution of noncoding DNA: how much junk, how much func?
Castillo-Davis, C. I. (2005) · Trends in Genetics · doi:10.1016/j.tig.2005.08.001 · Cited by 39
Zhao, L., Svetec, N., & Begun, D. J. (2024) · Annual Review of Genetics · doi:10.1146/annurev-genet-111523-102413 · Cited by 38
“While there are a few cases where conserved gene loss may be adaptive (91, 102, 141), it seems more likely that the turnover of young de novo genes reflects their loss by drift as the selective environment changes over time.”
Marchetti, L., Francisco, D. M. F., Soldati, S. G., Jahromi, N. H., Barcos, S., Gruber, I., Pareja, J. R., Thiriot, A., von Andrian, U. H., Deutsch, U., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202149238 · Cited by 42
A Novel ENU-Mutation in Ankyrin-1 Disrupts Malaria Parasite Maturation in Red Blood Cells of Mice
Greth, A., Lampkin, S., Mayura-Guru, P., Rodda, F., Drysdale, K. E., Roberts-Thomson, M., McMorran, B. J., Foote, S. J., & Burgio, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038999 · Cited by 38
“vivax infection [12].”
Kano, F. S., de Souza, A. M., Torres, L. D. M., Costa, M. A., Souza-Silva, F. A., Sanchez, B. A. M., Fontes, C. J. F., Soares, I. S., de Brito, C. F. A., de Carvalho, L. H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32254-z · Cited by 47
Golassa, L., Amenga-Etego, L. N.-K., Lo, E. Y. Y., & Amambua‐Ngwa, A. (2020) · Malaria Journal · doi:10.1186/s12936-020-03372-9 · Cited by 39
Rh, Kell, Duffy, Kidd and Diego blood group system polymorphism in Brazilian Japanese descendants
Flôres, M. A. L. R., Visentainer, J. E. L., Guelsin, G. A. S., Fracasso, A. D. S., de Melo, F. C., Hashimoto, M. N., & Sell, A. M. (2013) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2013.09.014 · Cited by 37
“01 allele): this mutation impairs the promoter activity in erythroid cells by disrupting a binding site for GATA-1 erythroid transcription factor, and it can protect the individuals from malaria infestation [36].”
BackgroundLo, E. Y. Y., Hostetler, J. B., Yewhalaw, D., Pearson, R. D., Hamid, M. M. A., Gunalan, K., Kepple, D., Ford, A., Janies, D. A., Rayner, J. C., et al. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007222 · Cited by 39
Rausell, A., Luo, Y., Lopez, M., Seeleuthner, Y., Rapaport, F., Favier, A., Stenson, P. D., Cooper, D. N., Patin, É., Casanova, J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917993117 · Cited by 44
The dimeric form of CXCL12 binds to atypical chemokine receptor 1
Gutjahr, J. C., Crawford, K. S., Jensen, D. R., Naik, P., Peterson, F. C., Samson, G. P. B., Legler, D. F., Duchêne, J., Veldkamp, C. T., Rot, A., et al. (2021) · Science Signaling · doi:10.1126/scisignal.abc9012 · Cited by 38
“A prevalent ACKR1 polymorphism present in the majority of individuals of African ancestry abolishes its expression on RBCs (28), thus conferring a resistance to P. vivax and P. knowlesi malaria (17).”
BackgroundInfluentialHorne, K., & Woolley, I. J. (2009) · Inflammation Research · doi:10.1007/s00011-009-0023-9 · Cited by 36
“This null phenotype is created by a mutation in the GATA-1 binding motif of the erythrocyte promoter [26].”
BackgroundThe potential of blood group genotyping for transfusion medicine practice
Westhoff, C. M. (2008) · Immunohematology · doi:10.21307/immunohematology-2019-297 · Cited by 36
Phenotypic expression of pyruvate kinase deficiency and protection against malaria in a mouse model
Min-Oo, G., Fortin, A., Tam, M.-F., Gros, P., & Stevenson, M. (2004) · Genes & Immunity · doi:10.1038/sj.gene.6364069 · Cited by 35
Expression of chemokine decoy receptors and their ligands at the porcine maternal–fetal interface
Wessels, J. M., Linton, N. F., Heuvel, M. J. V. D., Cnossen, S. A., Edwards, A. K., Croy, B. A., & Tayade, C. (2010) · Immunology and Cell Biology · doi:10.1038/icb.2010.95 · Cited by 35
Rodríguez-Trelles, F., Tarrío, R., & Ayala, F. J. (2005) · BioEssays · doi:10.1002/bies.20241 · Cited by 42
“example, one at the FY locus that affects expression in erythroid cells but not in other tissues,((61,62)) and others at the”
BackgroundDetection of blood group genes using multiplex SNaPshot method
Palacajornsuk, P., Halter, C., Isakova, V., Tarnawski, M. J., Farmar, J. G., Reid, M. E., & Chaudhuri, A. (2009) · Transfusion · doi:10.1111/j.1537-2995.2008.02053.x · Cited by 35
“Although the FYA/B SNP site determined the sample to be heterozygous, it did not necessarily mean to be of Fy(a+b+) phenotype as the FYB gene could be silent due to GATA box mutation.(12) Determination of GATA site mutation revealed that FYB allele was active.”
BackgroundDuffy Antigen Polymorphisms Do Not Alter Progression of HIV in African Americans in the MACS Cohort
Horne, K., Li, X., Jacobson, L. P., Palella, F. J., Jamieson, B. D., Margolick, J. B., Martinson, J. J., Turkozu, V., Visvanathan, K., & Woolley, I. J. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.04.013 · Cited by 35
Schwessinger, R., Suciu, M. C., McGowan, S. J., Telenius, J., Taylor, S., Higgs, D. R., & Hughes, J. R. (2017) · Genome Research · doi:10.1101/gr.220202.117 · Cited by 35
“The T-to-C substitution in theACKR1 gene promoter abrogates its expression (Tournamille et al. 1995), which Sasquatch detects as a strong damage score of 1.98 (Fig.”
BackgroundInfluentialThe use of next‐generation sequencing for the determination of rare blood group genotypes
Jakobsen, M. A., Dellgren, C., Sheppard, C., Yazer, M. H., & Sprogøe, U. (2017) · Transfusion Medicine · doi:10.1111/tme.12496 · Cited by 34
“However, studies have shown that SNPs or SNVs in non-coding regions, like promoter regions and splice sites, also affect the expression of blood group antigens and must be considered for a complete blood group antigen profile (Tournamille et al., 1995; Lucien et al., 1998; Lomas-Francis & Reid, 2010; Meny, 2010; Reid…”
BackgroundNew insights into human immunity from ancient genomics
Kerner, G., Patin, É., & Quintana‐Murci, L. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2021.04.006 · Cited by 38
“Indeed FY*O carriers do not express the Duffy antigen/chemokine receptor, which is required for the invasion of human erythrocytes by vivax merozoites [51,52].”
BackgroundSpecies-Specific Features of DARC, the Primate Receptor for Plasmodium vivax and Plasmodium knowlesi
Demogines, A., Truong, K., & Sawyer, S. L. (2011) · Molecular Biology and Evolution · doi:10.1093/molbev/msr204 · Cited by 41
Carvalho, T. A., Queiroz, M. G., Cardoso, G. L., Diniz, I. G., Silva, A. N. L. M. D., Pinto, A. Y. N., & Guerreiro, J. F. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-430 · Cited by 34
Enhanced Expression of Duffy Antigen in the Lungs During Suppurative Pneumonia
Lee, J. S., Frevert, C. W., Thorning, D., Segerer, S., Alpers, C. E., Cartron, J., Colin, Y., Wong, V. A., Martin, T. R., & Goodman, R. B. (2003) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540305100204 · Cited by 35
“…in Suppurative Pneumonia 165 ders erythrocytes Duffy-negative in the majority of African–Americans is a mutation occurring in the erythroidspecific promoter region and would not alter Duffy expression on nonerythroid cells (Olsson et al. 1998; Peiper et al. 1995; Tournamille et al. 1995).”
BackgroundSelf-citationUnveiling P. vivax invasion pathways in Duffy-negative individuals
Bouyssou, I., Hoss, S. E., Doderer-Lang, C., Schoenhals, M. J., Rasoloharimanana, L. T., Vigan-Womas, I., Ratsimbasoa, A. C., Abate, A., Golassa, L., Mabilotte, S., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.11.007 · Cited by 33
The value of DNA analysis for antigens in the Duffy blood group system
Castilho, L. M. (2007) · Transfusion · doi:10.1111/j.1537-2995.2007.01307.x · Cited by 34
FY polymorphisms and vivax malaria in inhabitants of Amazonas State, Brazil
Albuquerque, S. R. L., Cavalcante, F. D. O., Sanguino, E. C. B., Tezza, L. C., Chacón, F. H., Castilho, L. M., & Dos‐Santos, M. C. (2010) · Parasitology Research · doi:10.1007/s00436-010-1745-x · Cited by 33
“…(UNICAMP), Campinas, Brazil M. C. dos Santos Universidade Federal do Amazonas (UFAM), Manaus, Brazil and the SNP –33T>C on GATA box (Mallinson et al. 1995; Miller 1994; Parasol et al. 1998; Tournamille et al. 1995) with vivax malaria parasite density in inhabitants of the Amazon State, Brazil.”
BackgroundPractical approaches and costs for provisioning safe transfusions during anti‐CD38 therapy
Anani, W. Q., Marchan, M., Bensing, K. M., Schanen, M., Piefer, C., Gottschall, J. L., & Denomme, G. A. (2017) · Transfusion · doi:10.1111/trf.14021 · Cited by 35
“MM and Fy silencing mutations are more common in African Americans, and as a result, serologic typing of our patient cohort would not reveal Fy(b1) antigen tolerance in seven patients.(1,32) Rh variants are also more common among African Americans and detecting partial Rh antigens can be difficult with monoclonal typi…”
BackgroundAtypical Chemokine Receptors in Cardiovascular Disease
Gencer, S., van der Vorst, E. P. C., Aslani, M., Weber, C., Döring, Y., & Duchêne, J. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1676988 · Cited by 34
DNA Analysis of Duffy Genes in American Blacks
Moulds, J. M., Hayes, S., & Wells, T. D. (1998) · Vox Sanguinis · doi:10.1046/j.1423-0410.1998.7440248.x · Cited by 33
Forward genetics of infectious diseases: immunological impact
Casanova, J., Schurr, E., Abel, L., & Skamene, E. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02289-5 · Cited by 34
Metadata
- Authors
- Tournamille, C., Colin, Y., Cartron, J. P., & Le Van Kim, C.
- Affiliations
- Inserm (FR)
- Venue
- Nature Genetics
- Published
- 1995-06
- Volume
- 10
- Issue
- 2
- Pages
- 224-228
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2080491517
- Cited by
- 741
- References
- 32
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 23 · 2023: 28 · 2022: 20 · 2021: 28 · 2020: 27 · 2019: 23 · 2018: 22 · 2017: 27 · 2016: 21 · 2015: 22 · 2014: 25 · 2013: 33 · 2012: 25
- FWCI
- 20.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- Duffy blood group system, promoter mutations, erythroid gene expression, Plasmodium vivax, chemokine receptors, single-exon genes, African Americans
- MeSH terms
- Antigens, Protozoan, Base Sequence, Carrier Proteins, Chromosome Mapping, DNA-Binding Proteins, Duffy Blood-Group System, Erythrocytes, Genotype, Humans, Molecular Sequence Data, Mutation, Promoter Regions, Genetic, Receptors, Cell Surface, Transcription Factors, Transcription, Genetic, Tumor Cells, Cultured, Protozoan Proteins, Gene Expression, Black People, Erythroid-Specific DNA-Binding Factors, GATA1 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.